JTCS St. Jude Medical
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David A. Fullerton
Robert C. McIntyre, Jr.
Max B. Mitchell
Frederick L. Grover
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fullerton, D. A.
Right arrow Articles by Grover, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fullerton, D. A.
Right arrow Articles by Grover, F. L.

J Thorac Cardiovasc Surg 1995;109:212-217
© 1995 Mosby, Inc.


CARDIAC AND PULMONARY REPLACEMENT

Lung transplantation with cardiopulmonary bypass exaggerates pulmonary vasomotor dysfunction in the transplanted lung

David A. Fullerton, MD (by invitation), Robert C. McIntyre, Jr., MD (by invitation), Max B. Mitchell, MD (by invitation), David N. Campell, MD (by invitation), Frederick L. Grover, MD (by invitation)


Denver, Colo.

Supported by National Institutes of Health grant R29HL49398.

Address for reprints: David A. Fullerton, MD, Cardiothoracic Surgery, C-310, University of Colorado Health Sciences Center, 4200 East Ninth Ave., Denver, CO 80262

Abstract

Pulmonary vascular resistance is significantly increased in the transplanted lung. If cardiopulmonary bypass is required, the transplanted lung is reperfused with activated blood elements, which might exacerbate the reperfusion injury. The purpose of this study was to examine the influence of cardiopulmonary bypass on the following mechanisms of pulmonary vasomotor control in a dog model of autologous lung transplantation: (1) endothelium-dependent cyclic guanosine monophosphate–mediated relaxation (response to acetylcholine), (2) endothelium-independent cyclic guanosine monophosphate–mediated relaxation (response to nitroprusside), (3)ß–adrenergic cyclic adenosine monophosphate–mediated relaxation (response to isoproterenol). Autologous right lung transplants were performed with (n = 4 dogs) and without (n = 5 dogs) bypass. Lungs were stored in cold saline solution (4° C, 3 hours) before reimplantation. Pulmonary vasomotor control mechanisms were studied in isolated pulmonary atrial rings immediately after harvest and 1 hour after implantation. Ten rings were studied in each group at time. Statistical analysis was by analysis of variance. Without bypass, endothelium-dependent cyclic guanosine monophosphate–mediated relaxation andß–adrenergic cycle adenosine monophosphate–mediated relaxation were significantly impaired, although endothelium-independent cyclic guanosine monophosphate–mediated relaxation was not. Use of bypass produced significantly greater impairment of both endothelium-dependent cyclic guanosine monophosphate–mediated relaxation andß-adrenergic cyclic adenosine monophosphate–mediated relaxation. In addition, use of bypass produced significant dysfunction of endothelium-independent cyclic guanosine monophosphate–mediated relaxation as well. We concluded that using cardiopulmonary bypass to perform lung transplantation greatly exaggerates pulmonary vasomotor dysfunction in the transplanted lung. This dysfunction may contribute to significantly higher pulmonary vascular resistance in the transplanted lung if cardiopulmonary bypass is used. (J THORACCARDIOVASCSURG1995;109-212-7)




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Saitoh, M. Tsuchida, T. Koike, K. Satoh, M. Haga, T. Aoki, S.-i. Toyabe, and J.-i. Hayashi
Ultrafiltration attenuates cardiopulmonary bypass-induced acute lung injury in a canine model of single-lung transplantation
J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1447 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. L. Lau, D. M. Hoganson, B. F. Meyers, R. J. Damiano Jr, and G. A. Patterson
Use of an Apical Heart Suction Device for Exposure in Lung Transplantation
Ann. Thorac. Surg., April 1, 2006; 81(4): 1524 - 1525.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. Y. Szeto, D. Kreisel, G. C. Karakousis, A. Pochettino, D. H. Sterman, R. M. Kotloff, S. M. Arcasoy, D. A. Zisman, N. P. Blumenthal, R. J. Gallop, et al.
Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome
J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 241 - 249.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Fujita, H. Date, K. Ueda, I. Nagahiro, M. Aoe, A. Andou, and N. Shimizu
Experimental study on size matching in a canine living-donor lobar lung transplant model
J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 104 - 109.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Khatchatourian, C. Chevalley, A. Spiliopoulos, and M. Licker
Myocardial revascularization and bilateral lung transplantation without cardiopulmonary bypass
Eur. J. Cardiothorac. Surg., November 1, 2001; 20(5): 1042 - 1044.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Yoshida, N. A. Flavahan, M. Horibe, N. G. Smedira, and P. A. Murray
Endothelial defect mediates attenuated vasorelaxant response to isoproterenol after lung transplantation
Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H159 - H166.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. C. Sheridan, T. N. Hodges, M. R. Zamora, D. L. Lynch, J. M. Brown, D. N. Campbell, and F. L. Grover
Acute and chronic effects of bilateral lung transplantation without cardiopulmonary bypass on the first transplanted lung
Ann. Thorac. Surg., November 1, 1998; 66(5): 1755 - 1758.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
P. S. Myles
Aspects of Anesthesia for Lung Transplantation
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1998; 2(2): 140 - 154.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. A. Fullerton and R. C. McIntyre Jr
Inhaled Nitric Oxide: Therapeutic Applications in Cardiothoracic Surgery
Ann. Thorac. Surg., June 1, 1996; 61(6): 1856 - 1864.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Date, A. N. Triantafillou, E. P. Trulock, M. S. Pohl, J. D. Cooper, and G.A. Patterson
INHALED NITRIC OXIDE REDUCES HUMAN LUNG ALLOGRAFT DYSFUNCTION
J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 913 - 919.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. A. Fullerton, M. B. Mitchell, D. N. Jones, A. Maki, and R. C. McIntyre Jr.
PULMONARY VASOMOTOR DYSFUNCTION IS PRODUCED WITH CHRONICALLY HIGH PULMONARY BLOOD FLOW
J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 190 - 197.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The American Association for Thoracic Surgery.